Scaling up the national methadone maintenance treatment program in China: achievements and challenges

Zunyou Wu(Chinese Center For Disease Control and Prevention), Keming Rou(Chinese Center For Disease Control and Prevention), Sheena G. Sullivan(The Royal Melbourne Hospital), Wei Luo(Chinese Center For Disease Control and Prevention), Yuantao Hao(Peking University), Chenhui Wang(Cleveland Clinic Lerner College of Medicine), Jiaying Li(Chinese Center For Disease Control and Prevention), Fei Li(Xiamen Medical College), Xu Cao(First Hospital of China Medical University), Xiaoman Sun(Chinese Center For Disease Control and Prevention)
International Journal of Epidemiology
November 26, 2010
10.1093/ije/dyq210
Cited by 167

Related Papers

Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells
|Nature Medicine|2012|634
Decreased Influenza Activity During the COVID-19 Pandemic — United States, Australia, Chile, and South Africa, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|591
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020
|American Journal of Transplantation|2020|366
Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness
|American Journal of Epidemiology|2016|344